Actively Recruiting
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Led by Jona Hattangadi-Gluth · Updated on 2024-06-18
250
Participants Needed
1
Research Sites
621 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor patients undergoing fractionated radiation therapy to the brain. Quantitative neuroimaging, radiation dose information, and directed neurocognitive testing will be acquired through this study to improve understanding of cognitive changes associated with radiation dosage to non-targeted tissue, and will provide the basis for evidence-based cognitive- sparing brain radiotherapy.
CONDITIONS
Official Title
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years or older
- Karnofsky performance status (KPS) 670
- Life expectancy of at least 1 year
- Primary brain tumor patients who will receive fractionated partial brain radiation therapy
- Able to complete neurocognitive assessments
You will not qualify if you...
- Unable to undergo MRI with contrast
- Prior brain radiation therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Moores Cancer Center
San Diego, California, United States, 92037
Actively Recruiting
Research Team
S
Sheila Medina
CONTACT
J
Jona Hattangadi-Gluth, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here